People trying to put a valuation on IMU for just its CF33/OnCARlytics need simply take one of the worlds leading cancer drugs and use a multiple of 5 times to get a low ball number for what we have.
Keytruda has annual revenues of just under $30 billion so a low ball offer will be $150 billion or over $20 AUD per share. That’s a LOW ball number so if it’s a takeover of our entire portfolio try $30 per share and it’s probably still a little low.
Enjoy the journey.
Why IMU is a multi multi bagger, page-20902
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |